MP27-06 DEVELOPMENT OF A NEW PROGNOSTIC MODEL TO PREDICT SURVIVAL OF PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA RECEIVING FIRST-LINE GEMCITABINE PLUS CISPLATIN CHEMOTHERAPY: MULTICENTER RETROSPECTIVE STUDY BY THE SAPPORO MEDICAL UNIVERSITY UROLOGIC ONCOLOGY CONSORTIUM (SUOC)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.